Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review

Angiotensin II therapy in refractory septic shock: which patient can benefit most? A narrative review

Abstract Patients with septic shock who experience refractory hypotension despite adequate fluid resuscitation and high-dose noradrenaline have high mortality rates. To improve outcomes, evidence-based guidelines recommend starting a second vasopressor, such as vasopressin, if noradrenaline doses ex...

Full description

Saved in:
Bibliographic Details
Main Authors: Irene Coloretti, Andrea Genovese, J. Pedro Teixeira, Anusha Cherian, Ricard Ferrer, Giovanni Landoni, Marc Leone, Massimo Girardis, Nathan D. Nielsen
Format: Article
Language:English
Published: BMC 2024-02-01
Series:Journal of Anesthesia, Analgesia and Critical Care
Subjects:
Angiotensin II
Septic shock
Refractory shock
Vasopressors
Online Access:https://doi.org/10.1186/s44158-024-00150-w
Tags: Add Tag
No Tags, Be the first to tag this record!
Be the first to leave a comment!
You must be logged in first

Similar Items